Neogen Corporation
NASDAQ:NEOGMedical - Diagnostics & Research
+$0.16 today
- Market cap
- $2.42B
- Beta
- 1.80
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$2.80
Volume 1.79M
Average 2.53M
NEOG Income Before Tax
Profit after all operating and non-operating items but before income tax.
Neogen CorporationNASDAQ: NEOG
Income Before Tax · Q1 FY2027 · quarter ended Aug 2026
Income before tax turns negative
Q1 FY2027 income before tax was -$14.9M, compared with $43.81M a year earlier. Trailing-twelve-month income before tax was -$67.66M.
Context
- Income before tax amounted to 1.0% of revenue in FY2026, down 125.6 pp from a year earlier.
- Income before tax grew in size in 1 of the last 3 fiscal years.
- FY2026 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly income before tax holds near -$14.9M or moves back toward the trailing-twelve-month quarterly average of -$16.92M.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Before Tax history
USD · from the income statement
- Latest · FY2026
- (9M) USD
- Year-over-year change
- +99.2%
| Period | Period end | Income Before Tax | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-31 | (9M) | +99.2% |
| FY2025 | 2025-05-31 | (1.13B) | -7821.1% |
| FY2024 | 2024-05-31 | (14.31M) | +35.1% |
| FY2023 | 2023-05-31 | (22.04M) | -136.6% |
| FY2022 | 2022-05-31 | 60.21M | — |
Income Before Tax vs competitors
How NEOG compares with its peers on the latest reported figures
- NEOG's LTM Aug 2026 income before tax of -$67.66M is the 6th highest of the 7 companies compared; the peer median is $849.68M.
- Its year-over-year change of +93.7% is the 2nd highest of 7, against a peer median of +6.3%.
- Income before tax amounts to 7.7% of revenue for NEOG, versus a peer median of 14.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.95B | -69.0% | +8.6% | 9.0% | |
| LTM Jun 2026 | $3.27B | -1.4% | +8.2% | 34.4% | |
| LTM Sep 2026 | $1.48B | +16.1% | +15.5% | 31.7% | |
| LTM Sep 2026 | $220.38M | +13.9% | +14.2% | 19.9% | |
| LTM Mar 2026 | $128.85M | +154.9% | -2.0% | 8.6% | |
| LTM Aug 2026 | -$67.66M | +93.7% | — | 7.7% | |
| LTM Sep 2026 | -$92M | -475.0% | — | 1.8% | |
| Peer median (excluding NEOG) | $849.68M | +6.3% | +8.6% | 14.4% | |
Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Revenue | 527.16M | 822.45M | 924.22M | 894.66M | 870.4M |
| Cost of Revenue | 284.15M | 416.49M | 461.59M | 473.29M | 461.9M |
| Gross Profit | 243.01M | 405.96M | 462.64M | 421.38M | 408.5M |
| Gross Margin | 46.1% | 49.4% | 50.1% | 47.1% | 46.9% |
| Research & Development | 17.05M | 26.04M | 22.48M | 21.09M | 18.4M |
| Selling, General & Admin | 167.35M | 342.4M | 382.76M | 401.97M | 411.7M |
| Operating Expenses | 184.4M | 368.44M | 385.21M | 411.96M | 430.1M |
| Depreciation & Amortization | 24.13M | 90.47M | 121.23M | 125.67M | 116.3M |
| EBITDA | 84.34M | 124.39M | 182.6M | (937.75M) | 164.9M |
| EBITDA Margin | 16.0% | 15.1% | 19.8% | -104.8% | 18.9% |
| Operating Income | 58.62M | 37.52M | 77.43M | 9.42M | (21.6M) |
| Operating Margin | 11.1% | 4.6% | 8.4% | 1.1% | -2.5% |
| Interest Income | 1.34M | 3.17M | 6.36M | 3.11M | 0 |
| Interest Expense | 72K | 55.96M | 73.39M | 71.62M | 57.6M |
| Other Income / Expenses | 1.59M | (59.56M) | (91.73M) | (1.14B) | 12.6M |
| Income Before Tax | 60.21M | (22.04M) | (14.31M) | (1.13B) | (9M) |
| Pre-Tax Margin | 11.4% | -2.7% | -1.5% | -126.7% | -1.0% |
| Income Tax Expense | 11.9M | 828K | (4.88M) | (41.07M) | (1.1M) |
| Net Income | 48.31M | (22.87M) | (9.42M) | (1.09B) | (7.9M) |
| Net Margin | 9.2% | -2.8% | -1.0% | -122.1% | -0.9% |
| EPS (Basic) | 0.45 | (0.12) | (0.04) | (5.03) | (0.04) |
| EPS (Diluted) | 0.45 | (0.12) | (0.04) | (5.03) | (0.04) |
| Weighted Avg Shares | 107.68M | 188.88M | 216.48M | 216.89M | 217.5M |
| Weighted Avg Shares (Diluted) | 108.02M | 188.88M | 216.48M | 216.89M | 217.5M |
Neogen Corporation
NASDAQ:NEOG
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.